Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHF1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | MYBPC1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | DGKQ | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | LGALS8 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | RASSF7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CAPN15 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | MYO1A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | LINC00094 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | HLA-DQB2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ADCK5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |